← 블로그 목록으로
COLUMN

Ice-Skating on Breaking Glaciers: When Volatility Becomes the Asset Class

Supreme Court tariff blocks and pharma innovation collide—why the winners aren't betting on stability but on optionality amid constitutional uncertainty.

📅 2026년 2월 23일👁 0 조회

The trading floor has a new rhythm: Supreme Court injunctions arrive faster than earnings calls. Friday's tariff blockade wasn't just legal theater—it repriced sovereign execution risk for every dollar-denominated asset. While lawyers parse Commerce Clause boundaries, portfolio managers face a starker truth: we're ice-skating on breaking glaciers now, where agility beats prediction.

Consider the paradox playing out across sectors. Eli Lilly launches a single-pen Zepbound delivery system the same week Europe calls American trade policy "pure chaos." One represents inelastic demand meeting frictionless innovation—GLP-1 users don't stop mid-treatment over regulatory noise. The other exposes supply chains built on assumptions of treaty permanence. Spot the difference? Pricing power versus policy dependency.

The bull case says fundamentals outlast headlines. Fair enough—but when constitutional checks intervene in tariff execution, we've crossed from noise into structural repricing territory. Anthropic's Amodei heading to the Pentagon signals where smart capital flows: defense-adjacent AI with bipartisan durability, not cyclical plays requiring stable trade frameworks.

Even weather offers lessons. Blizzard-paralyzed East Coast airports waive change fees—a microcosm of operational flexibility trumping rigid planning. Airlines, counterintuitively, emerge better positioned for consolidation when crisis forces balance sheet discipline competitors lack.

The portfolio implication? Overweight inelastic demand moats (obesity drugs, defense tech), underweight anything requiring regulatory clarity timelines. Your 60/40 allocation was designed for glaciers that stayed frozen. If you want to catch these structural shifts before the crowd repositions, CREST's analytical tools track where institutional footprints actually move—not where commentary assumes they will.
#policy_volatility#pharma_innovation#defense_AI#portfolio_strategy#regulatory_risk

📌 참고 자료

https://www.cnbc.com/2026/02/21/blizzard-prompts-airlines-waive-flight-change-fees.htmlhttps://www.cnbc.com/2026/02/23/eli-lilly-launches-zepbound-obesity-drug-pen-one-month-doses.htmlhttps://www.cnbc.com/2026/02/23/trump-15percent-global-tariff-europe-eu-uk-reaction.html

🔗 이 글 공유하기

🔔 실시간 매도 신호 받기

무료로 가입하고 보유 종목의 매도 타이밍을 실시간으로 확인하세요.

무료로 시작하기 →